|
FANCF expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.212200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.326800E-01 |
| Normal-vs-Stage2 |
5.564200E-01 |
| Normal-vs-Stage3 |
3.488400E-01 |
| Normal-vs-Stage4 |
2.523400E-01 |
| Stage1-vs-Stage2 |
3.890400E-01 |
| Stage1-vs-Stage3 |
4.128800E-01 |
| Stage1-vs-Stage4 |
7.783800E-02 |
| Stage2-vs-Stage3 |
2.199800E-01 |
| Stage2-vs-Stage4 |
8.255600E-01 |
| Stage3-vs-Stage4 |
4.046000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.725200E-01 |
| Normal-vs-AfricanAmerican |
2.239800E-01 |
| Normal-vs-Asian |
2.509800E-01 |
| Caucasian-vs-AfricanAmerican |
2.094600E-01 |
| Caucasian-vs-Asian |
3.184000E-01 |
| AfricanAmerican-vs-Asian |
9.832000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.070000E-01 |
| Normal-vs-Female |
6.625000E-01 |
| Male-vs-Female |
4.403800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.669200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.005200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.866600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.282300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.591200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.282800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.463800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.943000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.987600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.575950E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.923600E-01 |
| Normal-vs-Grade 2 |
6.477000E-01 |
| Normal-vs-Grade 3 |
6.444000E-01 |
| Normal-vs-Grade 4 |
4.715400E-01 |
| Grade 1-vs-Grade 2 |
8.497400E-01 |
| Grade 1-vs-Grade 3 |
8.273000E-01 |
| Grade 1-vs-Grade 4 |
7.030800E-01 |
| Grade 2-vs-Grade 3 |
2.510800E-01 |
| Grade 2-vs-Grade 4 |
2.194600E-01 |
| Grade 3-vs-Grade 4 |
6.584000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.730000E-01 |
| Normal-vs-ccB subtype |
5.461000E-01 |
| ccA subtype-vs-ccB subtype |
2.826400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.412200E-01 |
| Normal-vs-N1 |
9.288400E-01 |
| N0-vs-N1 |
9.168400E-01 |
|
|
